Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: JDP raises $17M in series A

    JDP Therapeutics Inc. (Blue Bell, Pa.) said it raised $17 million in a series A round led by CoSci Med-Tech Co. Ltd. (Beijing, China). JDP plans to start a Phase III study of lead candidate JDP-205, an IV formulation of…

    Published on 6/29/2016
  • FINANCIAL NEWS: Biotech stocks bounce after Brexit woes

    Biotech indices rebounded Tuesday, taking back some of their losses following last week's Brexit vote. The BioCentury 100 Index gained 176.16 (4%) to 4,584.23, with gainers outnumbering decliners 97-3. It had slid 8.1% …

    Published on 6/28/2016
  • FINANCIAL NEWS: Intensity raises $10M in series A

    Intensity Therapeutics Inc. (Westport, Conn.) said it raised $10 million in an oversubscribed series A financing from Batterson Venture Capital, VCapital, FastForward Innovations, SalvaRx Group, Declan Doogan and Jim …

    Published on 6/28/2016
  • FINANCIAL NEWS: Storm Therapeutics raises L12M in series A round

    Storm Therapeutics Ltd. (Cambridge, U.K.) raised L12 million ($16.1 million) in a series A round from existing investors Imperial Innovations Group plc (LSE:IVO), Cambridge Innovation Capital and Merck Ventures, as well…

    Published on 6/28/2016
  • FINANCIAL NEWS: Biotech stocks' slide continues

    Biotech stocks sank again Monday as global markets continued to react to news of last week's Brexit vote. The BioCentury 100 lost 144.22 (3.2%) to 4,408.07, with decliners outpacing gainers 95-5. The close was the index…

    Published on 6/27/2016
  • FINANCIAL NEWS: Biotechs sink, markets hammered on Brexit news

    Biotech stocks sank Friday amid a worldwide sell-off on news that U.K. voters approved a referendum to leave the EU. The BioCentury 100 Index fell 246.47 (5.1%) to 4,552.30, with decliners outnumbering gainers 97-3.The …

    Published on 6/24/2016
  • FINANCIAL NEWS: CRISPR Therapeutics adds $38M to series B round

    Gene editing company CRISPR Therapeutics AG (Basel, Switzerland) raised $38 million in the final close of its series B round, bringing the round's total to about $140 million. Participating were new institutional …

    Published on 6/24/2016
  • FINANCIAL NEWS: Affiris raises EUR 10M

    Affiris AG (Vienna, Austria) said it raised EUR 10 million ($11.3 million) from FCPB Affi GmbH and existing investors Santo Holding GmbH and MIG Funds. Affiris expects Phase I data in 1Q17 for AT04A and AT06A, its …

    Published on 6/23/2016
  • FINANCIAL NEWS: Annexon raises $44M in B round

    Annexon Biosciences Inc. (South San Francisco, Calif.) raised $44 million in a series B round led by new investor New Enterprise Associates. New investor Correlation Ventures also participated, as did existing investors…

    Published on 6/23/2016
  • FINANCIAL NEWS: IFM Therapeutics raises $27M series A round

    Immunotherapy newco IFM Therapeutics Inc. (Cambridge, Mass.) raised $27 million in a series A round led by Atlas Venture and Abingworth. Novartis AG (NYSE:NVS; SIX:NOVN) also participated. IFM is developing small …

    Published on 6/22/2016
  • FINANCIAL NEWS: Paratek raises $55.3M in follow-on

    Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) raised $55.3 million through the sale of 4.3 million shares at $13 in a follow-on underwritten by Leerink, Guggenheim, Ladenburg Thalmann and BTIG. Paratek proposed to sell 3.8…

    Published on 6/22/2016
  • FINANCIAL NEWS: Selecta prices $70M IPO

    Immunomodulatory company Selecta Biosciences Inc. (NASDAQ:SELB) was unchanged its first day of trading Wednesday after raising $70 million through the sale of 5 million shares at $14 in an IPO. The price valued Selecta …

    Published on 6/22/2016
  • FINANCIAL NEWS: Global Blood raises $120M in follow-on

    Global Blood Therapeutics Inc. (NASDAQ:GBT) raised $120 million through the sale of 6.4 million shares at $18.75 in a bumped-up follow-on. JPMorgan, Morgan Stanley, Cowen and Wedbush PacGrow are underwriters.The company…

    Published on 6/21/2016
  • FINANCIAL NEWS: Morgenthaler passes away

    Morgenthaler Ventures founder David Morgenthaler passed away on Monday at age 96. Morgenthaler also helped found the National Venture Capital Association (NVCA), where he was a past president and then chair.

    Published on 6/21/2016
  • FINANCIAL NEWS: Wu joins Carlyle Group

    The Carlyle Group (NASDAQ:CG) named Jesse Wu senior advisor to its Asia buyout team. Wu was chairman of the China unit of Johnson & Johnson (NYSE:JNJ).

    Published on 6/21/2016
  • FINANCIAL NEWS: F2G raises $60M for antifungals

    F2G Ltd. (Manchester, U.K.) raised $60 million in a series E round led by new investor Sectoral Asset Management. New investors Novo A/S, Aisling Capital and Brace Pharma Capital also participated, as did existing …

    Published on 6/20/2016
  • FINANCIAL NEWS: Shenzhen Hepalink invests in TPG fund

    Chinese heparin producer Shenzhen Hepalink Pharmaceutical Co. Ltd. (SZSE:002399) invested $60 million in TPG Biotechnology Partners V, according to a regulatory filing. TPG did not respond to inquiries regarding the …

    Published on 6/20/2016
  • FINANCIAL NEWS: GlycoMimetics' follow-on brings in $20.1M

    GlycoMimetics Inc. (NASDAQ:GLYC) raised $20.1 million through the sale of 3.3 million shares at $6.10 in a follow-on underwritten by Jefferies, Cowen, Stifel and SunTrust. GlycoMimetics proposed the offering after …

    Published on 6/17/2016
  • FINANCIAL NEWS: Innocoll raises $40.1M follow-on

    Innocoll Holdings plc (NASDAQ:INNL) raised $40.1 million through the sale of 5.7 million shares at $7 in a follow-on underwritten by Morgan Stanley, Piper Jaffray, Stifel, FBR and Janney Montgomery Scott. Innocoll …

    Published on 6/17/2016
  • FINANCIAL NEWS: 1315 Capital closes $200M first fund

    1315 Capital closed its first fund at $200 million. The Philadelphia-based firm plans to invest in commercial-stage companies including specialty pharmaceutical, medtech and healthcare services companies. The firm's LPs…

    Published on 6/16/2016
  • FINANCIAL NEWS: Arkin, Phoenix form $60M investment vehicle

    Arkin Holdings partnered with Israeli insurance company Phoenix Group (Tel Aviv:PHOE) to create Arkin Bio-Ventures, a joint venture through which they plan to invest about $60 million in biopharma companies. The …

    Published on 6/16/2016
  • FINANCIAL NEWS: Fibrotic disease company Blade raises $45M

    Anti-fibrotic play Blade Therapeutics Inc. (South San Francisco, Calif.) raised $45 million in a series B round led by new investor Deerfield. New investors Pfizer Venture Investments, the Novartis Institutes for …

    Published on 6/16/2016
  • FINANCIAL NEWS: Mersana raises $33M in series C round

    Antibody-drug conjugate (ADC) developer Mersana Therapeutics Inc. (Cambridge, Mass.) raised $33 million in a series C round led by new investor Wellington Management Company. Also participating were new investors …

    Published on 6/16/2016
  • FINANCIAL NEWS: Antibiotic play Allecra raises EUR 22M

    Allecra Therapeutics GmbH (Lorrach, Germany) raised EUR 22 million ($24.8 million) in an untranched series B round led by new investor Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild …

    Published on 6/15/2016
  • FINANCIAL NEWS: Cancer play Rgenix raises $33M

    Rgenix Inc. (New York, N.Y.) raised $33 million in a series B round led by new investors Novo A/S (Hellerup, Denmark) and Sofinnova Partners. Existing investors including Partnership Fund for New York City, Alexandria …

    Published on 6/15/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993